Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-25-014718
Filing Date
2025-05-16
Accepted
2025-05-16 16:34:29
Documents
1
Period of Report
2025-05-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3103
  Complete submission text file 0001127602-25-014718.txt   4592
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Issuer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 333 LAKESIDE DRIVE FOSTER CITY CA 94404
Business Address
Dickinson Andrew D (Reporting) CIK: 0001310204 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19731 | Film No.: 25959852